Galectin Therapeutics Inc. Common Stock (GALT)

Typically moves ±5.20% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-13 ESTIMATED

Galectin Therapeutics Inc. Common Stock (GALT) has reported earnings 21 times since May 17, 2021. The stock moves an average of ±5.20% the day after reporting, closing higher 52.4% of the time. Its largest post-earnings gain was +8.35% (Mar 31, 2026) and its largest decline was -19.41% (Mar 31, 2025). The next earnings report is predicted for 2026-11-13 (estimated).

Earnings reactions

How GALT moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.20%

Positive %

52.4%

Negative %

47.6%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 14, 2026	☀ PRE	-2.54%	open_in_new
May 15, 2026	☀ PRE	-7.43%	open_in_new
Mar 31, 2026	☀ PRE	+8.35%	open_in_new
Nov 14, 2025	☀ PRE	+0.91%	open_in_new
Aug 14, 2025	☀ PRE	+2.59%	open_in_new
May 15, 2025	☀ PRE	+0.76%	open_in_new
Mar 31, 2025	☀ PRE	-19.41%	open_in_new
Nov 14, 2024	☀ PRE	-2.92%	open_in_new
Aug 13, 2024	☀ PRE	+5.66%	open_in_new
May 15, 2024	☀ PRE	+7.37%	open_in_new
Nov 13, 2023	☀ PRE	-6.25%	open_in_new
Aug 14, 2023	☀ PRE	+4.26%	open_in_new
May 15, 2023	☀ PRE	-4.91%	open_in_new
Mar 30, 2023	☀ PRE	+3.9%	open_in_new
Nov 14, 2022	☀ PRE	+0%	open_in_new
Aug 15, 2022	☀ PRE	+4.33%	open_in_new
May 16, 2022	☀ PRE	-5.9%	open_in_new
Mar 31, 2022	☀ PRE	-8.33%	open_in_new
Nov 15, 2021	☀ PRE	-6.64%	open_in_new
Aug 16, 2021	☀ PRE	-2.94%	open_in_new
May 17, 2021	☀ PRE	+3.8%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.20%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 17 →

Funds holding

$22111153

Total value held

Buying

11 added · 4 reduced

Blackrock, Inc.

$13865957 +273.90%

State Street Corp

$2634495 +119.70%

Northern Trust Corp

$1793569 +196.32%

Ubs Group Ag

$1017641 NEW BUY

Bank Of New York Mellon Corp

$490644 NEW BUY

SEC Filing Types

description SCHEDULE 13D/A

1 chevron_right

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
10-Q	20260814	open_in_new SEC.gov
8-K	20260814	open_in_new SEC.gov
4	20260804	open_in_new SEC.gov
8-K	20260804	open_in_new SEC.gov
SCHEDULE 13D/A	20260804	open_in_new SEC.gov
4	20260716	open_in_new SEC.gov
4	20260630	open_in_new SEC.gov
4	20260630	open_in_new SEC.gov
144	20260629	open_in_new SEC.gov
144	20260626	open_in_new SEC.gov

Frequently asked about GALT earnings

When does Galectin Therapeutics Inc. Common Stock report earnings next? expand_more

Galectin Therapeutics Inc. Common Stock (GALT)'s next earnings date is estimated for 2026-11-13. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GALT stock move after earnings? expand_more

Over 21 reports, GALT has moved an average of ±5.20% the session after earnings, closing higher 52.4% of the time.

What was GALT's biggest post-earnings move? expand_more

GALT's largest post-earnings gain on record was +8.35% on Mar 31, 2026, and its largest decline was -19.41% on Mar 31, 2025.

Where can I find Galectin Therapeutics Inc. Common Stock's SEC filings? expand_more

All of Galectin Therapeutics Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.